C-myc is expressed in mouse skeletal muscle nuclei during post-natal maturation

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 7, 1998, Pages 811-821

  Veal, E A ^a   Jackson, M J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

C myc; Dystrophic; Skeletal muscle; Transcription factor

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; ELECTROPHORESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; SKELETAL MUSCLE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL NUCLEUS; DNA; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, MYC; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER;

ANIMALIA;

EID: 0032127307     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00032-6     Document Type: Article

References (34)

1. Amati B., Land H. Myc-Mad-Max: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4:1994;102-108.
2. Sejersen T., Sümegi J., Ringertz N.R. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation defective myoblasts. J. Cell. Physiol. 125:1985;465-470.
3. Spizz G., Roman D., Strauss A., Olson E.N. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J. Biol. Chem. 261:1986;9483-9488.
4. Hesketh J.E., Whitelaw P.F. The role of cellular oncogenes in myogenesis and muscle cell hypertrophy. Int. J. Biochem. 24:1992;193-203.
5. Izumo S., Nadal-Ginard B., Mahdavi V. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. U.S.A. 85:1988;339-343.
6. Koromo I., Kurabayashi M., Takaku F., Yazaki Y. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ. Res. 62:1988;1075-1079.
7. Mulvagh S.L., Michael L.H., Perryman M.B., Roberts R., Schneider M.D. A haemodynamic load in vivo induces cardiac expression of the cellular oncogene c-myc. Biochem. Biophys. Res. Commun. 147:1987;627-636.
8. Lee D.M., Dawes N.J., Cox V.M., Hesketh J.E., Goldspink D.F. Immunolocalisation of proto-oncogene expression in mechanically stimulated skeletal muscle. Biochem. Soc. Trans. 23:1995;329S.
9. Whitelaw P.F., Hesketh J.E. Expression of c-myc and c-fos in rat skeletal muscle. Biochem. J. 281:1992;143-147.
10. Amati B., Dalton S., Brooks M.W., Littlewood T.D., Evan G.I., Land H. Transcriptional activation by the human c-myc oncoprotein in yeast requires interaction with Max. Nature. 359:1992;423-426.
11. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin, the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
12. McArdle A., Edwards R.H.T., Jackson M.J. How does dystrophin deficiency lead to muscle degeneration? Lessons from the mdx mouse. Neuromusc. Disord. 5:1995;445-456.
13. Veal E.A., Jackson M.J. Expression of c-fos and c-myc in satellite cell cultures from dystrophic mdx and control mouse muscle. Biochem. Soc. Trans. 23:1995;456S.
14. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 270:1977;725-727.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. J. Sambrook, E. Frisch, T. Maniatis, Molecular Cloning, 2nd ed., Cold Spring Harbor, New York, 1989.
17. C.L. Dent, D.S. Latchman, The DNA mobility shift assay. Transcription factors, in: D.S. Latchman (Ed.), A Practical Approach, Oxford University Press, Oxford, 1993, pp. 1-26.
18. Lukasuik K., Kaczmarek L. AP-1 and CRE DNA binding activities in rat brain following pentylenetetrazole induced seizures. Brain Res. 643:1994;227-233.
19. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:1985;3610-3616.
20. Vincent S., Marty L., Fort P. S26 ribosomal RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res. 21:1993;1498.
21. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-437.
22. Endo T., Nadal-Ginard B. Transcription and post-transcriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol. Cell. Biol. 6:1986;1412-1421.
23. Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.I., Land H. Oncogenic activity of the c-myc protein requires dimerisation with Max. Cell. 72:1993;233-245.
24. Amati B., Littlewood T.D., Evan G.I., Land H. The c-Myc protein induces cell cycle progression and apoptosis through dimerisation with Max. EMBO J. 12:1993;5083-5087.
25. Jansen-Dürr P., Meichle A., Steiner P., Pagano M., Finke K., Botz J., Wessbecher J., Draetta G., Eilers M. Differential modulation of the cyclin gene expression by MYC. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3685-3689.
26. Eilers M., Schirm S., Bishop J.M. The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10:1991;133-141.
27. Wagner A.J., Meyers C., Laimins L.A., Hay N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:1993;879-883.
28. Galaktionov K., Chen X., Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511-517.
29. Askew D., Ashmun R., Simmons B., Cleveland J. Constitutive c-myc expression in IL-3 dependant myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene. 6:1991;1915-1922.
30. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
31. Matsuda R., Nishikawa A., Tanaka H. Visualization of dystrophic muscle fibres in mdx mouse by vital staining with Evans Blue: evidence of apoptosis in dystrophin- deficient muscle. J. Biochem. 118:1995;959-964.
32. Sandri M., Carraro U., Podhorska-Okolov M., Rizzi C., Arslan P., Monti D., Francheschi C. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibres after exercise. FEBS Lett. 373:1995;291-295.
33. Tidball J.G., Albrecht D.E., Lokensgard B.E., Spencer M.J. Apoptosis precedes necrosis of dystrophin- deficient muscle. J. Cell Sci. 108:1995;2197-2204.
34. Veal E.A., Jackson M.J. Expression of programmed cell death-related genes in dystrophic mdx and control mouse muscle. Biochem. Soc. Trans. 24:1996;486S.